Viridian Therapeutics, Inc.\DE (VRDN) Change in Receivables (2013 - 2020)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Change in Receivables of -$48000.0 for Q4 2020, up 74.87% quarter-over-quarter from -$191000.0 in Q3 2020.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Change in Receivables (2013 - 2020) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Change in Receivables history runs 8 years deep, the most recent figure standing at -$48000.0 for Q4 2020.
- In Q4 2020, Change in Receivables changed N/A year-over-year to -$48000.0; the TTM figure through Dec 2020 stood at -$99000.0 (changed N/A YoY), while the FY2020 annual figure was -$99000.0, down 217.86% from the prior year.
- Change in Receivables for Q4 2020 stood at -$48000.0, up from -$191000.0 in the prior quarter.
- The five-year high for Change in Receivables was $3.4 million in Q1 2018, with the low at -$3.6 million in Q2 2018.
- The 5-year median for Change in Receivables is $96000.0 (2017), against an average of $61210.5.
- The sharpest annual moves came in 2016 and 2017: Change in Receivables sank 2044.12% in 2016, then surged 7363.64% in 2017.
- Viridian Therapeutics, Inc.\DE's Change in Receivables stood at $11000.0 in 2016, then soared by 7363.64% to $821000.0 in 2017, then sank by 265.41% to -$1.4 million in 2018, then surged by 170.32% to $955000.0 in 2019, then plunged by 105.03% to -$48000.0 in 2020.
- Business Quant data shows VRDN's Change in Receivables at -$48000.0 in Q4 2020, -$191000.0 in Q3 2020, and $244000.0 in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.42 Bn | 2.42 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -48,000.00 |
| Sep 30, 2020 | -191,000.00 |
| Jun 30, 2020 | 244,000.00 |
| Mar 31, 2020 | -104,000.00 |
| Sep 30, 2019 | 955,000.00 |
| Jun 30, 2019 | 301,000.00 |
| Mar 31, 2019 | -18,000.00 |
| Dec 31, 2018 | -1.36 Mn |
| Sep 30, 2018 | 184,000.00 |
| Jun 30, 2018 | -3.61 Mn |
| Mar 31, 2018 | 3.35 Mn |
| Dec 31, 2017 | 821,000.00 |
| Sep 30, 2017 | 96,000.00 |
| Jun 30, 2017 | 262,000.00 |
| Mar 31, 2017 | 257,000.00 |
| Dec 31, 2016 | 11,000.00 |
| Sep 30, 2016 | -729,000.00 |
| Jun 30, 2016 | 798,000.00 |
| Mar 31, 2016 | -60,000.00 |
| Dec 31, 2015 | -153,000.00 |